Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer
GFC combined with cisplatin can target PA2G4 gene to regulate PI3K/AKT/GSK-3β Signaling pathway, inhibiting the invasion and migration of cisplatin resistant A2780/DDP cells in ovarian cancer.
Authors
- Lei Dou (ORCID: https://orcid.org/0000-0001-6441-4040)
- Rongjin Zhang
- Dongli Tian (ORCID: https://orcid.org/0000-0003-3074-0088)
- Ye Sun (ORCID: https://orcid.org/0000-0002-5810-5820)
- Fangmei Li (ORCID: https://orcid.org/0000-0003-0490-0324)
- Lei Deng (ORCID: https://orcid.org/0000-0003-2647-4610)
- Enting Lu
- Yi Zhang (ORCID: https://orcid.org/0000-0002-7453-6188)
- Xue Zhang (ORCID: https://orcid.org/0009-0004-0249-0581)
- Li Yin (ORCID: https://orcid.org/0000-0001-5280-0075)
- Yan Yan Yan
Institutions
- Shenyang Medical College (CN)
- Peking University (CN)
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1016/j.tranon.2024.102244
- Citations
- 3
- Primary Topic
- Medicinal Plant Pharmacodynamics Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40